STAT6 Modulator Compounds for Cancer and Inflammatory Disease
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for modulators of STAT6 to treat conditions associated with STAT6 signaling, particularly in the context of cancer and inflammatory diseases, as existing treatments are inadequate.
Innovation Solution
Development of compounds of Formula (I) and their pharmaceutically acceptable salts, which act as STAT6 modulators to regulate cell processes such as proliferation, differentiation, and apoptosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments are used for STAT6-related conditions, then treatment options are limited, but therapeutic effectiveness is insufficient
Solution Approach 1:
The patent employs parameter changes by developing a series of chemical compounds with varying structural parameters (different R groups, molecular weights, and chemical functionalities) to optimize STAT6 modulation. This allows tuning of binding affinity, selectivity, and pharmacological properties to achieve both effective therapy and multiple treatment options across different STAT6-related conditions
2Reliability
If new STAT6 modulators are developed, then therapeutic benefits improve, but development complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the complex drug development process into systematic stages: identifying core molecular scaffolds, optimizing specific R groups (R1a, R1b, R2, R3, R4, R5), evaluating in vitro activity, and assessing in vivo efficacy. This segmented approach to molecular optimization reduces overall development complexity while achieving therapeutic benefits
Solution Approach 2:
The patent uses parameter changes systematically by varying specific molecular parameters (such as R group substitutions, molecular weight, lipophilicity) to optimize STAT6 binding and modulation. This structured parameter optimization reduces development complexity compared to random compound discovery
Data Source
AI summary
The present disclosure relates generally to STAT6 modulators and uses thereof, and more specifically to compounds, salts, and compositions thereof useful for treating conditions associated with STAT6.